In the State of Bahia, Brazil, the incidence of snakebite was positively and strongly associated with municipality characteristics: planted areas of cocoa and coffee, and the size of domestic bred chicken and bovine livestocks 6 . During school years, medical students are well trained on diagnostics and treatment of some tropical diseases like visceral leishmaniasis, schistosomiasis, and leptospirosis. But this does not happen concerning the diagnostics and treatment of snakebite poisoning. Because of lack of knowledge about these cases, most physicians just refer their patients bitten by snakes to a antivenom reference center, without taking any antivenom measure. The time expended, while looking for the nearby antivenom center, may be crucial for the patient's health. Short time-to-treatment is essential to the case favourable evolution.
We made some preliminar analyses of data on the lethality of agricultural workers in Brazil, 2004-2015.
We found that some drawbacks still occur in the management of cases attended in antivenom centers, contributing to increase snakebite poisoning lethality, due to: a) the serum can simply be unavailable in the center; b) the type of the serum given to the patient can be inadequate to the snake that caused the accident. Five types of antivenom sera should be available to treat Brazilian snakebites; c) only a small number of ampoules is given to the patient. We should not blame only the Brazil's doctors and antivenom centers for the high incidence and high lethality of snakebites. The confrontation of this issue involves, at least, the coherent distribution of antivenom serum, continuous training of health care team, and health measures to protect farmers, the most vulnerable occupation to snakebites.
The serum presently used in Brazil is liquid, needs to be kept refrigerated (2-8 ºC) to prevent its denaturation, and its shelf life is relatively small (about three years). A lyophilized version of snake antivenom, more stable and durable, already exists in Europe. Therefore, it's urgent to expand the production and availability of lyophilized antivenoms that are indicated to the snakes types found in Brazil. Further, more research is needed concerning the production of polyvalent serum, that could prevent errors in antivenom therapy. There have been some advancements in the knowledge about this subject, but there is still much to evolve in the prevention, diagnosis, and treatment of snakebite poisoning. Snakebite poisoning shameful and unacceptable morbidity and lethality keeps on challenging Brazil.
